Cancer Research SABCS Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 53, 2472-2474, June 1, 1993]
© 1993 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tada, M.
Right arrow Articles by Sninsky, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tada, M.
Right arrow Articles by Sninsky, J. J.

Detection of ras Gene Mutations in Pancreatic Juice and Peripheral Blood of Patients with Pancreatic Adenocarcinoma

Minoru Tada, Masao Omata, Shigenobu Kawai, Hiromitsu Saisho, Masao Ohto, Randall K. Saiki and John J. Sninsky1

Second Department of Medicine, Faculty of Medicine, University of Tokyo [M. T., M. Om.], and First Department of Medicine, School of Medicine, Chiba University [S. K., H. S., M. Oh.], Japan, and Department of Human Genetics [R. K. S.] and Infectious Diseases [J. J. S.], Roche Molecular Systems, Inc., Alameda, California 94501

Pancreatic adenocarcinomas are known to have a high incidence of K-ras gene mutations. Differential diagnosis of pancreatic cancer and chronic pancreatitis sometimes presents a clinical dilemma. We recently developed a highly sensitive and specific polymerase chain reaction capable of detecting 3–30 copies of mutant K-ras genes harboring codon 12 single base changes in the presence of 300,000 normal copies. Mutant ras genes were detected in DNA purified from pancreatic juice from all 6 cases of pancreatic adenocarcinoma and 1 case of intraductal papillary neoplasms of the pancreas. In 2 of 6 other cases with pancreatic adenocarcinoma, circulating metastatic cells were detected in DNA purified from peripheral blood. Activated ras genes were not found in pancreatic juice of three control cases (chronic pancreatitis and choledocholithiasis) or in the peripheral blood of two patients with insulinomas. Notable conclusions of this study are that there can be significant levels of shed tumor cells in peripheral blood and an even higher number in pancreatic juice. In addition, two different K-ras mutations were found in some patients.

1 To whom requests for reprints should be addressed, at Roche Molecular Systems, Inc., 1145 Atlantic Avenue, Alameda, CA 94501.

Received 3/16/93. Accepted 4/20/93.




This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. Ohuchida, K. Mizumoto, J. Yu, H. Yamaguchi, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
S100A6 Is Increased in a Stepwise Manner during Pancreatic Carcinogenesis: Clinical Value of Expression Analysis in 98 Pancreatic Juice Samples
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 649 - 654.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Jimeno and M. Hidalgo
Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer.
Mol. Cancer Ther., April 1, 2006; 5(4): 787 - 796.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ohuchida, K. Mizumoto, D. Yamada, H. Yamaguchi, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
Clin. Cancer Res., April 1, 2006; 12(7): 2066 - 2069.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ohuchida, K. Mizumoto, N. Ishikawa, K. Fujii, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
The Role of S100A6 in Pancreatic Cancer Development and Its Clinical Implication as a Diagnostic Marker and Therapeutic Target
Clin. Cancer Res., November 1, 2005; 11(21): 7785 - 7793.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Goggins
Molecular Markers of Early Pancreatic Cancer
J. Clin. Oncol., July 10, 2005; 23(20): 4524 - 4531.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
D.A. TUVESON and S.R. HINGORANI
Ductal Pancreatic Cancer in Humans and Mice
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 65 - 72.
[Abstract] [PDF]

Home page
 GutHome page
A Khalid, R Pal, E Sasatomi, P Swalsky, A Slivka, D Whitcomb, and S Finkelstein
Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples
Gut, December 1, 2004; 53(12): 1860 - 1865.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
A. J. Jeffreys and C. A. May
DNA Enrichment by Allele-Specific Hybridization (DEASH): A Novel Method for Haplotyping and for Detecting Low-Frequency Base Substitutional Variants and Recombinant DNA Molecules
Genome Res., October 1, 2003; 13(10): 2316 - 2324.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
J. F. Parker, S. R. Florell, A. Alexander, J. A. DiSario, P. J. Shami, and S. A. Leachman
Pancreatic Carcinoma Surveillance in Patients With Familial Melanoma
Arch Dermatol, August 1, 2003; 139(8): 1019 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Mol. Pathol., June 1, 2003; 56(3): 172 - 179.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Gut, January 1, 2003; 52(1): 101 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. R. Heyen, E. R. Blasi, K. Nikula, R. Rocha, H. A. Daust, G. Frierdich, J. F. Van Vleet, P. De Ciechi, E. G. McMahon, and A. E. Rudolph
Structural, functional, and molecular characterization of the SHHF model of heart failure
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1775 - H1784.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Chen, S. Germer, R. Higuchi, G. Berkowitz, J. Godbold, and J. G. Wetmur
Kinetic Polymerase Chain Reaction on Pooled DNA: A High-Throughput, High-Efficiency Alternative in Genetic Epidemiological Studies
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 131 - 136.
[Abstract] [Full Text]

Home page
 GutHome page
S Kubicka, F Kuhnel, P Flemming, B Hain, N Kezmic, K L Rudolph, M Manns, and P N Meier
K-ras mutations in the bile of patients with primary sclerosing cholangitis
Gut, March 1, 2001; 48(3): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
E EFTHIMIOU, T CRNOGORAC-JURCEVIC, N R LEMOINE, and T A BRENTNALL
Inherited predisposition to pancreatic cancer
Gut, February 1, 2001; 48(2): 143 - 147.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Ashida, H. Okuda, M. Chikazawa, M. Tanimura, O. Sugita, Y. Yamamoto, S. Nakamura, M. Moriyama, and T. Shuin
Detection of Circulating Cancer Cells with von Hippel-Lindau Gene Mutation in Peripheral Blood of Patients with Renal Cell Carcinoma
Clin. Cancer Res., October 1, 2000; 6(10): 3817 - 3822.
[Abstract] [Full Text]

Home page
 BloodHome page
J.-M. Costa, D. Vidaud, I. Laurendeau, M. Vidaud, E. Fressinaud, J.-P. Moisan, A. David, D. Meyer, and J.-M. Lavergne
Somatic mosaicism and compound heterozygosity in female hemophilia B
Blood, August 15, 2000; 96(4): 1585 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. H. Hruban, M. Goggins, J. Parsons, and S. E. Kern
Progression Model for Pancreatic Cancer
Clin. Cancer Res., August 1, 2000; 6(8): 2969 - 2972.
[Full Text]

Home page
 Genome ResHome page
S. Germer, M. J. Holland, and R. Higuchi
High-Throughput SNP Allele-Frequency Determination in Pooled DNA Samples by Kinetic PCR
Genome Res., February 1, 2000; 10(2): 258 - 266.
[Abstract] [Full Text]

Home page
 GutHome page
K Tateishi, M Tada, M Yamagata, H Isayama, Y Komatsu, T Kawabe, Y Shiratori, and M Omata
High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions
Gut, November 1, 1999; 45(5): 737 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. D. Jayasena
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Clin. Chem., September 1, 1999; 45(9): 1628 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Vogelstein and K. W. Kinzler
Digital PCR
PNAS, August 3, 1999; 96(16): 9236 - 9241.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. Pantel, R. J. Cote, and O. Fodstad
Detection and Clinical Importance of Micrometastatic Disease
J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C.-J. Tseng, C. C. Pao, J.-D. Lin, Y.-K. Soong, J.-H. Hong, and S. Hsueh
Detection of Human Papillomavirus Types 16 and 18 mRNA in Peripheral Blood of Advanced Cervical Cancer Patients and Its Association With Prognosis
J. Clin. Oncol., May 1, 1999; 17(5): 1391 - 1391.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Yamaguchi, H. Watanabe, S. Yrdiran, K. Ohtsubo, Y. Motoo, T. Okai, and N. Sawabu
Detection of Mutations of p53 Tumor Suppressor Gene in Pancreatic Juice and Its Application to Diagnosis of Patients with Pancreatic Cancer: Comparison with K-ras Mutation
Clin. Cancer Res., May 1, 1999; 5(5): 1147 - 1153.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. D. J. Sturm, E. A. J. Rauws, R. H. Hruban, E. Caspers, T. B. Ramsoekh, K. Huibregtse, L. A. Noorduyn, and G. J. A. Offerhaus
Clinical Value of K-ras Codon 12 Analysis and Endobiliary Brush Cytology for the Diagnosis of Malignant Extrahepatic BileDuct Stenosis
Clin. Cancer Res., March 1, 1999; 5(3): 629 - 635.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Castells, P. Puig, J. Mora, J. Boadas, L. Boix, E. Urgell, M. Sole, G. Capella, F. Lluis, L. Fernandez-Cruz, et al.
K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance
J. Clin. Oncol., February 1, 1999; 17(2): 578 - 578.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
S. Germer and R. Higuchi
Single-Tube Genotyping without Oligonucleotide Probes
Genome Res., January 1, 1999; 9(1): 72 - 78.
[Abstract] [Full Text]

Home page
 BloodHome page
N. Frickhofen, E. Muller, M. Sandherr, T. Binder, M. Bangerter, C. Wiest, M. Enz, and H. Heimpel
Rearranged Ig Heavy Chain DNA Is Detectable in Cell-Free Blood Samples of Patients With B-Cell Neoplasia
Blood, December 15, 1997; 90(12): 4953 - 4960.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. Sidransky
Nucleic Acid-Based Methods for the Detection of Cancer
Science, November 7, 1997; 278(5340): 1054 - 1058.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
P. Nollau and C. Wagener
Methods for detection of point mutations: performance and quality assessment
Clin. Chem., July 1, 1997; 43(7): 1114 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
W. F. Maule, G. Ramadori, H. Munke, R. M. Schmid, G. Adler, and D. Seidler
Chronic Pancreatitis
N. Engl. J. Med., November 2, 1995; 333(18): 1221 - 1222.
[Full Text]

Home page
 Arch DermatolHome page
J. M. Spencer, S. M. Kahn, W. Jiang, V. A. DeLeo, and I. B. Weinstein
Activated ras Genes Occur in Human Actinic Keratoses, Premalignant Precursors to Squamous Cell Carcinomas
Arch Dermatol, July 1, 1995; 131(7): 796 - 800.
[Abstract] [PDF]

Home page
 NEJMHome page
J. A. Brennan, L. Mao, R. H. Hruban, J. O. Boyle, Y. J. Eby, W. M. Koch, S. N. Goodman, and D. Sidransky
Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck
N. Engl. J. Med., February 16, 1995; 332(7): 429 - 435.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. H. Hruban, P. van der Riet, Y. S. Erozan, and D. Sidransky
Molecular Biology and the Early Detection of Carcinoma of the Bladder -- The Case of Hubert H. Humphrey
N. Engl. J. Med., May 5, 1994; 330(18): 1276 - 1278.
[Full Text]

Home page
 Arch SurgHome page
S. D. Finkelstein, R. Przygodzki, V. E. Pricolo, R. Sayegh, A. Bakker, P. A. Swalsky, and G. Keller
K-ras-2 Topographic Genotyping of Pancreatic Adenocarcinoma
Arch Surg, April 1, 1994; 129(4): 367 - 373.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.